Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Buy Signal

|Includes:Intercept Pharmaceuticals (ICPT)

SYMBOL - ICPT

CURRENT SIGNAL - BUY on 12/04

CHART

Intercept Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat chronic liver diseases utilizing its proprietary bile acid chemistry. It primarily develops obeticholic acid, a bile acid analog that is in Phase III clinical trials for the treatment of primary biliary cirrhosis; in Phase IIa clinical trial to treat portal hypertension; in Phase IIb clinical trial for the treatment of nonalcoholic steatohepatitis; and in Phase IIa clinical trial to treat bile acid diarrhea. The company was founded in 2002 and is headquartered in New York, New York.

MARKET TREND SIGNAL

WWW.MARKETTRENDSIGNAL.COM

Market Trend Signal iphone App

Market Trend Signal - Stock Analysis Software and Trading System

twitter.com/MuscleStocks

www.facebook.com/MarketTrendSignal

Stocks: ICPT